logo
Sign in

PFE Stock Price, Chart, Stats & News

144.51B
Market cap
19.35x
Current P/E
8.73x
Forward P/E
6.78%
Dividend yield

PFE chart

1M
3M
1Y
5Y
Loading chart...

Fundamentals

Gross margin
70.33%
Operating margin
24.67%
Pretax margin
12.02%
Net margin
12.42%
Effective tax rate
-3.54%
ROA
3.73%
ROE
8.67%
D/E
0.78x
Interest coverage ratio
5.78x

PFE valuation

P/E
19.35x
P/S
2.46x
P/B
1.78x
P/CF
13.12x
P/FCF
16.94x
P/OCF
13.12x
PEG
-0.92x
EV multiple
5.21x

About

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands.

Similar securities

Based on sector and market capitalization

Report issue